JENNIFER FRANKLIN: Open Payments
NPI 1043758345 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 22 payments from 4 companies in 2025. Trend: 2023 $446 · 2024 $1,358 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $263 |
| Madrigal Pharmaceuticals | 3 | $170 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $150 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: Ozempic, REZDIFFRA, XIFAXAN, Wegovy.
Industry payments across IN — which companies pay providers there.
